In support of our observations, studies have shown that PIK3CA is mutated in up to 30% of CRC as well as other tumors such as breast, ovarian, and liver cancer [47] typically leading to activation of the PI3K/AKT/mTOR signaling pathway. The gene discussed is PIK3CA; the disease is colorectal carcinoma.